Ablative Therapy for Esophageal Dysplasia and Early Malignancy : Focus on RFA

Joint Authors

Hochwald, Steven N.
Nurkin, Steven J.
Tuttle, Rebecca

Source

BioMed Research International

Issue

Vol. 2014, Issue 2014 (31 Dec. 2014), pp.1-10, 10 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2014-07-21

Country of Publication

Egypt

No. of Pages

10

Main Subjects

Medicine

Abstract EN

Ablative therapies have been utilized with increasing frequency for the treatment of Barrett’s esophagus with and without dysplasia.

Multiple modalities are available for topical ablation of the esophagus, but radiofrequency ablation (RFA) remains the most commonly used.

There have been significant advances in technique since the introduction of RFA.

The aim of this paper is to review the indications, techniques, outcomes, and most common complications following esophageal ablation with RFA.

American Psychological Association (APA)

Tuttle, Rebecca& Nurkin, Steven J.& Hochwald, Steven N.. 2014. Ablative Therapy for Esophageal Dysplasia and Early Malignancy : Focus on RFA. BioMed Research International،Vol. 2014, no. 2014, pp.1-10.
https://search.emarefa.net/detail/BIM-487568

Modern Language Association (MLA)

Tuttle, Rebecca…[et al.]. Ablative Therapy for Esophageal Dysplasia and Early Malignancy : Focus on RFA. BioMed Research International No. 2014 (2014), pp.1-10.
https://search.emarefa.net/detail/BIM-487568

American Medical Association (AMA)

Tuttle, Rebecca& Nurkin, Steven J.& Hochwald, Steven N.. Ablative Therapy for Esophageal Dysplasia and Early Malignancy : Focus on RFA. BioMed Research International. 2014. Vol. 2014, no. 2014, pp.1-10.
https://search.emarefa.net/detail/BIM-487568

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-487568